Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-18-023122

Chief Operating Officer sold 482 shares at $0.50 ($242)

From the SEC's structured data for this filing

Trades in this filing

Keuer Thomas A · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-04-03 Sale : show line 1 in the form −482 $0.50 $242 13,153 D
Open-market sales · 482 sh · avg $0.50 · $242
Loading xslF345X03/doc4.xml…